Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Neoplasms 2Breast Neoplasms 2Tooth, Impacted 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Pain 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Acute 1Hematopoietic and Lymphatic System Neoplasm 1Gastrointestinal Neoplasms 1Facial Pain 1Chemotherapy-Induced Peripheral Neuropathy 1Cancer Pain 1Anxiety Disorders 1

Interventions

Fulvestrant 125Trastuzumab 114Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Capecitabine 72Anastrozole 72Cyclophosphamide 70Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 60trastuzumab deruxtecan 57Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 49Docetaxel 49Magnetic Resonance Spectroscopy 48Blood Specimen Collection 40olaparib 39Standard of Care 36Biopsy 33sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Doxorubicin 30Exercise 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Massage × 1 year × Clear all
NCT04202640 2026-03-18

PRESSODOU

Centre Oscar Lambret

Phase NA Terminated
80 enrolled
Breast

Breast Neoplasms

NCT02221700 2026-03-09

Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies

M.D. Anderson Cancer Center

Phase NA Active not recruiting
90 enrolled
BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡